Posts

Four in 10 Patients Receiving Chemo Develop Chronic Painful Neuropathy

Four in 10 Patients Receiving Chemo Develop Chronic Pai...

Feb 9, 2025 0

TUESDAY, Feb. 4, 2025 -- The pooled prevalence of chronic painful neuropathy is ...

Life's Crucial 9 Negatively Linked to Overactive Bladder

Life's Crucial 9 Negatively Linked to Overactive Bladder

Feb 9, 2025 0

WEDNESDAY, Feb. 5, 2025 -- Life's Crucial 9 (LC9), a recently proposed method fo...

Number of Anesthesiology Residents Applying to Pain Medicine Fellowships Decreasing

Number of Anesthesiology Residents Applying to Pain Med...

Feb 9, 2025 0

WEDNESDAY, Feb. 5, 2025 -- The number of anesthesiology residents applying to pa...

Elevated HDL Cholesterol Linked to Increased Risk for Glaucoma

Elevated HDL Cholesterol Linked to Increased Risk for G...

Feb 9, 2025 0

WEDNESDAY, Feb. 5, 2025 -- Elevated high-density lipoprotein cholesterol (HDL-C)...

Occupational Exposures Tied to Higher Risk for Vertigo

Occupational Exposures Tied to Higher Risk for Vertigo

Feb 9, 2025 0

WEDNESDAY, Feb. 5, 2025 -- Occupational exposure to noise and/or vibrations is a...

Preterm Birth Slightly Higher for Offspring of Young Male Patients With Cancer

Preterm Birth Slightly Higher for Offspring of Young Ma...

Feb 9, 2025 0

WEDNESDAY, Feb. 5, 2025 -- The prevalence of preterm birth is slightly higher am...

Minority Children Less Likely to Be Diagnosed With Migraine in Emergency Department

Minority Children Less Likely to Be Diagnosed With Migr...

Feb 9, 2025 0

WEDNESDAY, Feb. 5, 2025 -- Compared with non-Hispanic White (NHW) children, non-...

Early Childhood Stressful Life Events Linked to Increased Eczema Activity

Early Childhood Stressful Life Events Linked to Increas...

Feb 9, 2025 0

WEDNESDAY, Feb. 5, 2025 -- For children with atopic dermatitis (AD), early child...

Prescriptions for Obesity Management Drugs Increasing

Prescriptions for Obesity Management Drugs Increasing

Feb 9, 2025 0

THURSDAY, Feb. 6, 2025 -- Prescriptions of obesity management drugs (OMDs) have ...

Three All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TB

Three All-Oral Shortened Regimens Noninferior for Rifam...

Feb 9, 2025 0

THURSDAY, Feb. 6, 2025 -- Three all-oral shortened regimens have noninferior eff...

Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer

Nivolumab Added to Chemo Improves Response in ER+, HER2...

Feb 9, 2025 0

THURSDAY, Feb. 6, 2025 -- For patients with high-risk, early-stage estrogen rece...

HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia

HoLEP Double-n Technology Promising for Benign Prostati...

Feb 9, 2025 0

THURSDAY, Feb. 6, 2025 -- For men with benign prostatic hyperplasia (BPH), trans...

Weight Gain Common in Young Women After Breast Reduction Surgery

Weight Gain Common in Young Women After Breast Reductio...

Feb 9, 2025 0

THURSDAY, Feb. 6, 2025 -- Many young women gain weight in the years after breast...

FDA Approves Attruby (acoramidis) to Reduce Cardiovascular Death and Cardiovascular-Related Hospitalization in Patients with ATTR-CM

FDA Approves Attruby (acoramidis) to Reduce Cardiovascu...

Feb 9, 2025 0

PALO ALTO, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasd...

FDA Approves Simplified Dosing Regimen for Acetadote (N-acetylcysteine for injection)

FDA Approves Simplified Dosing Regimen for Acetadote (N...

Feb 9, 2025 0

NASHVILLE, Tenn., Dec. 9, 2024 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (...

Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del Trikafta-Responsive Variants

Vertex Announces U.S. FDA Approval for Trikafta (elexac...

Feb 9, 2025 0

BOSTON--(BUSINESS WIRE)--Dec. 20, 2024-- Vertex Pharmaceuticals Incorporated (Na...

FDA Approves Opdivo Qvantig (nivolumab and hyaluronidase-nvhy) Subcutaneous Injection for Use in Most Previously Approved Solid Tumor Opdivo (nivolumab) Indications

FDA Approves Opdivo Qvantig (nivolumab and hyaluronidas...

Feb 9, 2025 0

PRINCETON, N.J.--(BUSINESS WIRE) December 27, 2024 -- Bristol Myers Squibb (NYS...

FDA Approves Onapgo (apomorphine hydrochloride) for the Treatment of Motor Fluctuations in Adults with Advanced Parkinson’s Disease

FDA Approves Onapgo (apomorphine hydrochloride) for the...

Feb 9, 2025 0

ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc....

FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Treatment of Diabetic Macular Edema

FDA Approves Genentech’s Susvimo as the First and Only ...

Feb 9, 2025 0

South San Francisco, CA -- February 4, 2025 -- Genentech, a member of the Roche ...

GURU INC. Issues Voluntary Nationwide Recall of Infla-650 Herbal Dietary Supplement Capsules Due to Hidden Drug Ingredients

GURU INC. Issues Voluntary Nationwide Recall of Infla-6...

Feb 9, 2025 0

Audience: Consumer Lilburn, GA, July 16, 2024 -- GURU INC. is voluntarily recall...

FDA, FTC Continue Joint Effort to Protect Consumers Against Companies Illegally Selling Copycat Delta-8 THC Food Products

FDA, FTC Continue Joint Effort to Protect Consumers Aga...

Feb 9, 2025 0

Audience: Consumer July 16, 2024 -- Today, the U.S. Food and Drug Administration...

Endo USA, Inc. Issues Recall of One Lot of Clonazepam Orally Disintegrating Tablets Due to Mislabeling: Incorrect Strength on Product Carton

Endo USA, Inc. Issues Recall of One Lot of Clonazepam O...

Feb 9, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer MALVERN, PA, July 16, 202...

Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Issues Recall of One Lot of Healthy Living Over the Counter (OTC) Migraine Relief

Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Iss...

Feb 9, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer July 18, 2024 – East Windsor, ...

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nationwide Recall of One Lot of Acetaminophen Injection, 1000mg/100mL (10mg/mL) Bags

Hikma Pharmaceuticals USA Inc. Extends Voluntary Nation...

Feb 9, 2025 0

Audience: Healthcare Provider, Pharmacy, Consumer London, July 22, 2024 – Hikma ...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.